SavedAdd your journal

Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2021 / Cilt: 55 - Sayı: 1

Discussion of Histopathological Findings of 954 Breast Reduction Specimens

Soysal BAS
Cagatay ONER
Ali Can AYDİN
Ramazan UCAK
Selami Serhat SİRVAN
Semra KARSİDAG
Pages
42–48
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

One of the biggest advantages of reduction mammoplasty in addition to psychophysi- ological recovery is breast cancer risk reduction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Breast reduction is a frequently sought procedure by patients and one of the most commonly performed operations by plastic surgeons.
📊
Key Findings & Data:Methods: 477 patients who underwent reduction mammoplasty in the plastic surgery department between October 2013 and January 2020 were included in this study.
💡
Conclusion & Impact:One of the biggest advantages of reduction mammoplasty in addition to psychophysi- ological recovery is breast cancer risk reduction.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: Breast reduction is a frequently sought procedure by patients and one of the most commonly performed operations by plastic surgeons. Follow-up of histopathological results after reduction mammoplasty is very important. This study aimed to evaluate the histopathological results of patients undergoing bilateral reduction mammoplasty to determine the incidence of breast lesions and risk factors of high-risk breast lesions. Methods: 477 patients who underwent reduction mammoplasty in the plastic surgery department between October 2013 and January 2020 were included in this study. Patients were evaluated according to age, body mass index (BMI), comorbidity factors, tobacco use, family history and histopathological findings. Results: The mean age of patients was 42.43±12.05 years. Body mass index ranged from 23 to 34.6. As for comorbidity factors, 12 patients had hypertension, five patients had asthma and six patients had diabetes mellitus. Seventeen patients (3.6%) were smokers, and 25 (5.2%) patients had a family history of breast cancer. Among the patients, 2.3% were 20 years and under, 17.1% were between 21 and 30 years old, 21.5% were between 31 and 40 years old, 33.1% were between 41 and 50 years old, 18.2% were between 51 and 60 years old, and 7.5% were 60 years and above. 85.4% of histopathological findings consisted of normal breast tissue and nonproliferative breast lesion breast lesions. The incidences of proliferative breast lesions, atypical hyperplasia and in situ lesions were calculated as 5.7%, 2% and 0.4%, respectively. The mean follow-up period was 3.8±1.6 years. Conclusion: Although preoperative breast cancer screening methods are used before the reduction mammoplasty, high-risk lesions may be encountered afterwards. One of the biggest advantages of reduction mammoplasty in addition to psychophysi- ological recovery is breast cancer risk reduction.

🔖

Cite This Article

BAS, S., ONER, C., AYDİN, A. C., UCAK, R., SİRVAN, S. S., KARSİDAG, S. (2021). Discussion of Histopathological Findings of 954 Breast Reduction Specimens. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 55 - Sayı: 1, 42–48. https://ajindex.com/articles/402850

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Eggert E, Schuss R, Edsander-Nord A. Clinical outcome, qual- ity of life, patients' satisfaction, and aesthetic results, after re- duction mammaplasty. Scand J Plast Reconstr Surg Hand Surg 2009;43:201–6
  2. Findikcioglu K, Findikcioglu F, Bulam H, Sezgin B, Ozmen S. The impact of breast reduction surgery on the vertebral column. Ann Plast Surg 2013;70:639–42
  3. Sood R, Mount DL, Coleman JJ 3rd, Ranieri J, Sauter S, Mathur P, et al. Effects of reduction mammaplasty on pulmonary function and symptoms of macromastia. Plast Reconstr Surg 2003;111:688–94
  4. Ameican Society of Plastic Surgeons. ASPS plastic surgery sta- tistics report 2018. Available at: https://www.plasticsurgery. org/documents/News/Statistics/2018/plastic-surgery-statis- tics-full-report-2018.pdf. Accessed Jan 06, 2021
  5. Merkkola-von Schantz PA, Jahkola TA, Krogerus LA, Hukkinen KS, Kauhanen SM. Should we routinely analyze reduction mamm- aplasty specimens? J Plast Reconstr Aesthet Surg 2017;70:196– 202
  6. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 con- sensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 1998;122:1053–5
  7. Percent of new cases by age group: Female breast cancer. Avail- able at: http://seer.cancer.gov/statfacts/html/breasthtml. Ac- cessed Feb 1, 2016
  8. Blansfield JA, Kukora JS, Goldhahn RT Jr, Buinewicz BR. Suspicious findings in reduction mammaplasty specimens: review of 182 consecutive patients. Ann Plast Surg 2004;52:126¬–30
  9. Ayhan S, Başterzi Y, Yavuzer R, Latifoğlu O, Cenetoğlu S, Atabay K, et al. Histologic profiles of breast reduction specimens. Aesthetic Plast Surg 2002;26:203–5
  10. Pitanguy I, Torres E, Salgado F, Pires Viana GA. Breast pathology and reduction mammaplasty. Plast Reconstr Surg 2005;115:729– 34
  11. Albayrak A, Mesci CG, Güler G. Histopathological findings ob - tained from reduction mammoplasty specimens. Turk J Med Sci 2015;45:1374–9
  12. Acevedo F, Armengol VD, Deng Z, Tang R, Coopey SB, Braun D, et al. Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions. Breast Cancer Res Treat 2019;173:201–7
  13. Ambaye AB, MacLennan SE, Goodwin AJ, Suppan T, Naud S, Weaver DL. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study. Plast Reconstr Surg 2009;124:1386–92.